Meditation and mental well being

Indian Journal of Physiology and Pharmacology

Volumn 50, Issue 3, 2006, Pages 205-214

  Sharma, Ratna ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; ELECTROENCEPHALOGRAM; EMOTION; HUMAN; HUMAN RELATION; MEDITATION; MENTAL DISEASE; MENTAL HEALTH; NERVE CELL PLASTICITY; NEUROSCIENCE; PSYCHOLOGICAL ASPECT; REVIEW; SCHIZOPHRENIA; SKILL; SUBSTANCE ABUSE; WELLBEING; YOGA;

CONSCIOUSNESS; HISTORY, 20TH CENTURY; HUMANS; MEDITATION; MENTAL HEALTH;

EID: 33747090338     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Lou HC, Kjaer TW, Friberg L, Wildschiodtz G, Holm S, Nowak M. A 150-H2O PET study of meditation and the resting state of normal consciousness. Hum Brain Map 1999; 7: 98-105.
2. Jevning R, Anand R, Biedebach M, Fernando G. Effects on regional cerebral blood flow of transcendental meditation. Physiol Behav 1996; 59: 399-402.
3. Herzog H, Lele VR, Kuwert T, Langen KJ, Kops ER, Feinendegen LE. Changed pattern of regional glucose metabolism during yoga meditative relaxation. Neuropsychobiology 1990; 23: 182-187.
4. Davidson RJ, Goleman D. The role of attention in meditation and hypnosis: A psychobiological-perspective on transformations of consciousness. The International J Clinic Exprntl Hypnosis 1977; Xxv: 291-308.
5. Davidson RJ, Schwartz GE. The psychobiology of relaxation and related states: a multi-process theory. In D I Mostofsky (Ed), Behavior control and modification of physiological activity. Eaglewood Ciffs, N.J. Prentice-Hall 1976; pp. 399-442.
6. Goleman D. The Buddha of meditation and states of consciousness. Part 1: The teachings. J Transpers Psychol 1972; 4: 1-14.
7. Otis LS. Meditation or simulated meditation by nonpredisposed volunteers: some psychological changes. In: E Taub (Chm) The psychobiology of meditation symposium presented at the American Psychological Association, Montreal, August 1973.
8. Barrows KA, Jacobs BP. Mindbody medicine. An introduction and review of the literature. Medical Clinical of North America 2002; 86: 11-31.
9. Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: state of the science, implications for practice. Journal of American Board of Family Practice 2003; 16: 131-147.
10. Anand BK, Chhina GS, Singh B. Some aspects of electroencephalographic studies in yogis. Electroencephalography and Clinical Neurophysiology 1961; 13: 452-456.
11. Wallace RK, Benson H. The physiology of meditation. Scientific American 1972; 226: 85-90.
12. Vempati RP, Telles S. Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychological Reports 2002; 90: 487-494.
13. Wallace RK, Dillbeck M, Jacobe E, Harrington B. The effects, of the transcendental meditation and TM-Siddhi program on the aging process. International Journal of Neuroscience 1982; 16: 53-58.
14. Schneider RH, Nidich SI, Salerno JW, Sharma HM, Robinson CE, Nidich RJ, Alexander CN. Lower lipid peroxide levels in practitioners of ranscendental meditation. Psychosomatic Medicine 1998; 60: 38-41.
15. Kiecolt-Giaser, JK McGuire, L Robles TE, Glaser R. Emotions, morbidity and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 2003; 53: 83-107.
16. Sharma R, Manjunatha S, Bijlani RL. Effect of Yoga on Subjective Well Being. Indian J Physiol Pharmacol 2004; 48(5, Suppl): 238.
17. Gupta NS, Khera RP, Vempati R, Sharma, RL Bijlani. Effect of yoga based life style intervention on State Trait anxiety. Indian J Physiol Pharmacol 2006; 50(1): 41-47.
18. Singh Y, RP Vempati, R Sharma, RK Yadav, RL Bijlani. Effect of short - term Yoga based intervention on Anxiety. Souvenier. 14th International Conference on Frontiers YOGA RESEARCH AND APPLICATIONS. Swami Vivekananda Yoga Anusandhan Sansthan, Bangalore, December 2003; 18-21.
19. Bijlani RL, Vempati RP, Yadav RK, Ray RB, Gupta V, Sharma R, Mehta N, Mahapatra SC. A Brief but comprehensive lifestyle education program based on Yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Alt Complement Med 2005; 11: 267-274.
20. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW, Smythe GA. The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologi 1992; 35: 835-843.
21. Bijlani RL, Manchanda SK. Stress as a diabetogenic factor. Indian J Physiol Pharmacol 1981; 25: 184-188.
22. Paul L, Feldman J, Giardino N, Song H, Schmaling K. Psychological Aspects of Asthma. J Consult Clin Psychol 2002; 70(3): 691-711.
23. Murphy M, Donovan S. The physical and psychological effects of Meditation A review of contemporary research with a comprehensive bibliography 1999; 1931-1996. (2nd ed.) Sausalito, CA.
24. Sat Bir S Khalsa. Yoga as a therapeutic intervention: A bibliometric analysis of published research studies. Indian J Physiol Pharmacol 2004; 48(3): 269-285.
25. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999; 3: 11-21.
26. Ekman P, Davidson RJ, Matthieu Ricard, Alan Wallace B. Buddhist and Psychological Perspectives on Emotions and Well-Being. Current Directions in Psychological Science 2005; 14: 59-63.
27. Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ. Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proceedings of the National Academy of Sciences 2004; 101: 16369-16373.
28. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine 2003; 65: 564-570.
29. Davidson RJ, Jackson DC, Kalin NH. Emotion, plasticity, context, and regulation: perspectives from affective neuroscience. Psychol Bull 2000; 126: 890-909.
30. Bijlani RL. Influence of yoga on brain and behaviour: facts and speculations. Indian J Physiol Pharmacol 2004; 48(1): 1-5.
31. Slingsby BT, Stefano GB. Placebo: Harnessing the power within. Modern Aspects of Immunobiology 2000; 1: 144-146.
32. Sligsby BT, Stefano GB. The active ingredients in the sugar pill: Trust and belief. Placebo 2001; 2: 33-38.
33. Esch T, Guarna M, Bianchi E, Zhu W, Stefano GB. Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Medical Science Monitor 2004; 10: MS6-MS17.
34. Stefano GB, Fricchione GL, Slingsby BT, Benson H. The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Research: Brain Research Reviews 2001; 35: 1-19.
35. Stefkio GB, Fricchione GL. The biology of deception: The evolution of cognitive coping as a denial-like process. Medical Hypotheses 1995; 44: 311-314.
36. Benson H. The relaxation response. New York: William Morrow 1975.
37. Stefano GB, Esch T, Cadet P, Zhu W, Mantione K, Benson H. Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response. Medical Science Monitor 2003; 9: RA63-RA75.
38. Lazar S, Bush G, Gollub R, Fricchione GL, Khalsa G, Benson H. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000; 11: 1585.
39. Newberg A, Alavi A, Baime M, Pourdehnad M, Santanna J, d'Aquili E. The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study. Psychiatry Research 2001; 106: 113-122.
40. Travis F, Tecce JJ, Guttman J. Cortical plasticity, contingent negative variation, and transcendent experiences during practice of the Transcendental Meditation technique. Biological Psychology 2000; 55: 41-55.
41. Elias AN, Wilson AF. Serum hormonal concentrations following transcendental meditation-potential role of gamma aminobutyric acid. Medical Hypotheses 1995; 44: 287-291.
42. Newberg A, Pourdehnad M, Alavi A, d'Aquili EG. Cerebral blood flow during meditative prayer: Preliminary findings and methodological issues. Perceptual and Motor Skills 2003; 97: 625-630.
43. Critchley HD, Melmed RN, Featherstone E, Mathias CJ, Dolan RJ. Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain 2001; 124: 1003-1012.
44. Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE, Pbert L, Lenderking WR, Santorelli SF. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psych 1992; 149: 936-943.
45. Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psych 1995; 17: 192-200.
46. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulneas-based cognitive therapy. J Consult Clin Psychol 2000; 68: 615-623.
47. Teasdale JD, Segal Z, Williams MG. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behav Res Ther 1995; 33: 25-39.
48. Beauchamp-Turner DL, Levinson DM. Effects of meditation on stress, health, and affect. Medical-Psychother Int J 1992; 5: 123-131.
49. Bernie S Siegel. Love Medicine and Miracle, 1986, Cox and Wyman Ltd Reading, Berkshire.